Purchase Order HHSN271201700165P
Award Date 2/22/17
Potential Completion Date 2/21/20
Potential Value $150K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a $113,258.16 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to Maris Solutions LLC, a small disadvantaged woman-owned business. The contract has a period of performance ending on February 29, 2016, and was awarded on August 31, 2015. The contract does not have a set-aside designation. The contract award does not reference a larger contract vehicle.</p>
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health, to Med Associates, Inc., a for-profit, woman-owned small business manufacturer and supplier of specialized scientific laboratory equipment and software. The contract award, valued at $18,898.50, is for the delivery of products that support research into substance use disorders, neurological processes, addiction mechanisms, and behavioral...
- This is a $112,329.81 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Maris Solutions LLC, a self-certified small disadvantaged business, woman-owned small business. The contract does not have a set-aside designation and the ultimate completion date is August 31, 2016. The contract is for unspecified products or services, as the original solicitation was not provided. There is no indication of any major subcontractors or that...
- The National Institute on Drug Abuse awarded a firm fixed-price purchase order to Rashid Adnan (UEI: LMD7VXK1MQV9) on March 6, 2020, with a ceiling value of $26,900. The contract, which was solicited without a set-aside designation, calls for the awardee to study the pathophysiology and develop related research deliverables, with work to be performed in Greenbelt, Maryland. The solicitation was posted on January 31, 2020, with a bid due date of February 14, 2020, and the contract ultimately...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services. The $19,910.40 firm fixed-price purchase order was awarded to Med Associates, Inc., a for-profit, woman-owned small business manufacturer of specialized scientific laboratory equipment and software. The contract is for the delivery of a SMARTCTRL 8-input/16-output package to replace retiring Coulbourn equipment that is essential for ongoing...
- This is a $25,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Kiipo CO., a self-certified small disadvantaged business. The contract is for custom digital biomarker exploration to support NIDA's Immediate Response Program (IRP) data processing and other ecological momentary assessment (EMA) and just-in-time adaptive intervention (JITAI) research activities. The contract does not have a set-aside designation and has...
- The U.S. National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, has awarded a $136,232.50 firm-fixed-price delivery order to Synectics For Management Decisions, Inc., a woman-owned small business. This delivery order was issued under the Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB) government-wide acquisition contract. The contract will provide web developer services to support NIDA's research programs...
- <p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>
- This is a $239,546.16 definitive contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Arm Consulting LLC, a certified Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract is for statistical data analysis support services to NIDA Headquarters. The contract is a firm fixed-price arrangement with a completion date of June 30, 2017. There is no set-aside designation mentioned for this...
- <p>This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for the delivery of 5,050 proprietary chemical compounds at 1 milligram and 2 x 1 milligram each. The total ceiling value of the contract is $126,150.00, and the ultimate completion date is March 30, 2017. The contract does not have a set-aside designation.</p>
This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian agency, to Edythe A. Wiggs, a for-profit woman-owned business. The contract has a period of performance through February 21, 2020 and was awarded on February 22, 2017. This contract does not appear to be associated with a larger contract vehicle and has no set-aside designation. The contract is for services or products related to the mission and programs of the National Institute on Drug Abuse, which conducts research on drug use and addiction.
Generated 4/1/25, 4:45 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $37.5k | 2/4/19 | |
| 1 | Exercise an Option | $37.5k | 1/8/18 | |
| Not listed | Not listed | $75.0k | 2/22/17 |